HeartBeam, Inc.
NCM: BEATLive Quote
📈 ZcoreAI Score
Our AI model analyzes HeartBeam, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get BEAT Z-Score →About HeartBeam, Inc.
Healthcare
Health Information Services
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.
📊 Fundamental Analysis
HeartBeam, Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
Return on Equity (ROE) is -987.3%, which indicates that capital utilization is currently under pressure.
At a current price of $1.15, BEAT currently trades near the bottom of its 52-week range (18%), indicating potential value or weakness (Range: $0.54 - $4.00).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$47.25M
Trailing P/E
--
Forward P/E
-2.17
Beta (5Y)
-0.64
52W High
$4.00
52W Low
$0.54
Avg Volume
1.19M
Day High
Day Low